Business Context and Reporting Period
This Form 6-K filing by Innate Pharma S.A. is dated December 11, 2025. The report serves to distribute a press release (Exhibit 99.1) to U.S. investors. The registrant is a foreign private issuer based in Marseille, France, and files annual reports under Form 20-F.
Key Financial Metrics
The filing text provided does not contain specific financial data. No values for revenue, profit, cash flow, margins, debt, or liquidity are disclosed in this document.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods.
Guidance, Outlook, and Risks
The filing references a press release dated December 11, 2025, but the content of that release is not included in the provided text. Consequently, no guidance, management commentary, risks, contingencies, or unusual items can be summarized from this source.
Investor Verification Checklist
- Verify the content of the referenced press release (Exhibit 99.1) for specific operational or financial updates.
- Confirm the nature of the announcement made on December 11, 2025, as the filing itself contains only administrative details.
- Review the company's most recent Form 20-F for detailed financial statements, as this Form 6-K does not include them.